264 related articles for article (PubMed ID: 9589048)
61. Prognostic value of DNA ploidy: 5-year follow-up of patients with resectable squamous cell carcinoma (SCC) of the lung.
Kasprzyk M; Dyszkiewicz W; Piwkowski C; Gasiorowski L; Kaczmarek E
Lung Cancer; 2006 Feb; 51(2):201-6. PubMed ID: 16375987
[TBL] [Abstract][Full Text] [Related]
62. Analysis of genetic alterations, classified according to their DNA ploidy pattern, in the progression of colorectal adenomas and early colorectal carcinomas.
Sugai T; Takahashi H; Habano W; Nakamura S; Sato K; Orii S; Suzuki K
J Pathol; 2003 Jun; 200(2):168-76. PubMed ID: 12754737
[TBL] [Abstract][Full Text] [Related]
63. [Studies on DNA content in ploidy patterns of esophageal cancer].
Rikitake H
Nihon Geka Gakkai Zasshi; 1990 May; 91(5):564-74. PubMed ID: 2385220
[TBL] [Abstract][Full Text] [Related]
64. [DNA ploidy of stem cells and prognosis of ductal adenocarcinoma of the pancreas].
Mellin W; Meyer J; Sasse W
Zentralbl Pathol; 1994 Aug; 140(3):237-42. PubMed ID: 7947631
[TBL] [Abstract][Full Text] [Related]
65. [DNA ploidy pattern, S-phase fraction as a prognostic factor of breast cancers].
Kimijima I; Katagata N; Tsuchiya A; Takenoshita S
Nihon Rinsho; 2000 Apr; 58 Suppl():401-6. PubMed ID: 11026024
[No Abstract] [Full Text] [Related]
66. DNA ploidy and S + G2M fraction (proliferative index) as prognostic determinants in human periampullary cancer.
Jorba R; Jaurrieta E; Bernat R; Verdaguer J; Fabregat J; Fernandez-Cruz L
Hepatogastroenterology; 1995; 42(5):740-7. PubMed ID: 8751244
[TBL] [Abstract][Full Text] [Related]
67. DNA and cell cycle analysis as prognostic indicators in breast tumors revisited.
Bagwell CB; Clark GM; Spyratos F; Chassevent A; Bendahl PO; Stål O; Killander D; Jourdan ML; Romain S; Hunsberger B; Wright S; Baldetorp B
Clin Lab Med; 2001 Dec; 21(4):875-95, x. PubMed ID: 11770293
[TBL] [Abstract][Full Text] [Related]
68. Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era.
Clark PE; Veys JA; Eskridge MR; Woodruff RD; Hall MC
Urol Oncol; 2005; 23(5):328-32. PubMed ID: 16144666
[TBL] [Abstract][Full Text] [Related]
69. DNA ploidy and cytonuclear area of peritumoral and paratumoral samples of mastectomy specimens: a useful prognostic marker?
Chávez-Uribe EM; Viñuela JE; Cameselle-Teijeiro J; Forteza J; Puñal JA; Otero JL; Puente-Dominguez JL
Eur J Surg; 2002; 168(1):37-41. PubMed ID: 12022369
[TBL] [Abstract][Full Text] [Related]
70. Intratumoral heterogeneity of DNA ploidy in breast carcinomas: a flow cytometric assessment of sampling techniques.
Schvimer M; Lash RH; Katzin WE
Cytometry; 1995 Dec; 22(4):292-6. PubMed ID: 8749779
[TBL] [Abstract][Full Text] [Related]
71. DNA ploidy and cell kinetic characteristics in canine non-Hodgkin's lymphoma.
Teske E; Rutteman GR; Kuipers-Dijkshoorn NJ; van Dierendonck JH; van Heerde P; Cornelisse CJ
Exp Hematol; 1993 Apr; 21(4):579-84. PubMed ID: 8462667
[TBL] [Abstract][Full Text] [Related]
72. Comparison of proliferation activity in breast carcinoma by flow cytometry analysis of S-phase and quantitative analysis of MIB-1.
Masood S; Bui MM; Lu L
Ann Clin Lab Sci; 1998; 28(6):315-23. PubMed ID: 9846198
[TBL] [Abstract][Full Text] [Related]
73. [A study of DNA heterogeneity on gastric cancer with serosal invasive exposure].
Tadaoka N; Aoki T; Hirai K; Tsukamoto T
Gan To Kagaku Ryoho; 1994 May; 21 Suppl 1():21-6. PubMed ID: 8203925
[TBL] [Abstract][Full Text] [Related]
74. Flow cytometric DNA analysis of breast cancer by two colour method using cytokeratin labeling for identification of tumour cells.
Kimmig R; Spelsberg H; Kapsner T; Untch M; Hepp H
Anal Cell Pathol; 1994 Oct; 7(3):205-15. PubMed ID: 7531483
[TBL] [Abstract][Full Text] [Related]
75. S-phase fraction and menopausal status as the most important prognostic factors of disease-free survival for node negative patients with breast cancer. A prospective study.
Lackowska B; Niezabitowski A; Ryś J; Skołyszewski J; Stelmach A; Gruchała A; Jaszcz-Gruchała A
Pol J Pathol; 2003; 54(2):101-10. PubMed ID: 14575418
[TBL] [Abstract][Full Text] [Related]
76. [Impulse cytophotometry and catamnesis in breast neoplasms].
Krug H; Schönfelder M
Acta Histochem Suppl; 1984; 30():117-27. PubMed ID: 6425932
[TBL] [Abstract][Full Text] [Related]
77. [DNA ploidy and results of first line chemotherapy in ovarian cancer patients].
Milczek T; Klasa-Mazurkiewicz D; Emerich J; Debniak J
Ginekol Pol; 2006 Aug; 77(8):589-96. PubMed ID: 17076189
[TBL] [Abstract][Full Text] [Related]
78. [DNA analysis of breast cancer].
Ohuchi N; Mori S
Gan To Kagaku Ryoho; 1991 Jan; 18(1):30-6. PubMed ID: 1987899
[TBL] [Abstract][Full Text] [Related]
79. Cytometry of breast carcinoma: significance of ploïdy balance and proliferation index.
Opfermann M; Brugal G; Vassilakos P
Cytometry; 1987 Mar; 8(2):217-24. PubMed ID: 3034530
[TBL] [Abstract][Full Text] [Related]
80. [Detection of intratumoral DNA heterogeneity in primary lung cancer using a multiple sampling method].
Mizobuchi K; Fujita Y; Hashikura H; Arimoto T; Nakagaki Y; Goto T; Fujii T; Iwasaki Y; Nakamura T; Nakagawa M
Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Oct; 32(10):963-9. PubMed ID: 7844914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
